New study aims to perfect radiation dose for liver cancer treatment
NCT ID NCT07345247
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study is testing a procedure called radiation segmentectomy for adults with liver cancer. Doctors deliver tiny radioactive resin beads directly to the tumor's blood supply to kill cancer cells while sparing healthy tissue. The goal is to find the best radiation dose for complete tumor shrinkage and to confirm the treatment is safe. 150 participants will be followed for at least 3 months after treatment.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Y-90 resin microspheres
- What this could lead to
- If successful, this could establish a standard dose for using resin microspheres in radiation segmentectomy, improving tumor control while minimizing liver damage.
- What could go wrong
- This is a single-center, non-randomized study with 150 participants. Results may not apply to all liver cancer patients, and there are risks of radiation-induced liver injury or incomplete tumor response.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LIVER CANCER, ADULT are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Acibadem Adana Hospital
RECRUITINGAdana, Turkey (Türkiye)
-
Acibadem Izmir Hospital
NOT_YET_RECRUITINGIzmir, Turkey (Türkiye)
-
Adana City Hospital
NOT_YET_RECRUITINGAdana, Turkey (Türkiye)
-
Bilkent City Hospital
NOT_YET_RECRUITINGAnkara, Turkey (Türkiye)
-
Cam ve Sakura Education and Reseach Hospital
RECRUITINGIstanbul, Turkey (Türkiye)
-
Cukurova University
NOT_YET_RECRUITINGAdana, Turkey (Türkiye)
-
Ege University
NOT_YET_RECRUITINGIzmir, Turkey (Türkiye)
-
Erciyes University
RECRUITINGKayseri, Turkey (Türkiye)
-
Gazi Yasargil Education and Research Hospital
NOT_YET_RECRUITINGDiyarbakır, Turkey (Türkiye)
-
Gulhane Education and Research Hospital
NOT_YET_RECRUITINGAnkara, Turkey (Türkiye)
-
Hacettepe University
RECRUITINGAnkara, Turkey (Türkiye)
-
Inonu University
RECRUITINGMalatya, Turkey (Türkiye)
-
Istanbul Unicersity Cerrahpasa Medical School
NOT_YET_RECRUITINGIstanbul, Turkey (Türkiye)
-
Istanbul University Capa Medical School
RECRUITINGIstanbul, Turkey (Türkiye)
-
Katip Celebi Education and Research Hospital
RECRUITINGIzmir, Turkey (Türkiye)
-
Kocaeli University
NOT_YET_RECRUITINGKocaeli, Turkey (Türkiye)
-
Konya Selcuk University
RECRUITINGKonya, Turkey (Türkiye)
-
Marmara University
RECRUITINGIstanbul, Turkey (Türkiye)
-
Mersin City Hospital
NOT_YET_RECRUITINGMersin, Turkey (Türkiye)
-
Pamukkale University
NOT_YET_RECRUITINGDenizli, Turkey (Türkiye)
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Exercise as medicine: tailored workouts may rebuild strength after cancer
- Can a heart drug help doctors see liver cancer better?
- Smart nursing cuts kidney damage risk in liver cancer patients
- Can eating only during an 8-10 hour window help liver cancer patients?
- New scan could help spare healthy liver during cancer radiation
- New trial matches liver cancer treatment to Tumor's Fat-Burning signature